FDA Clearance Tracker · P040046-S013
NATRELLE 410 HIGHLY COHESIVE ANATOMICALLY SHAPED BREAST IMPLANTS
Last checked: Nov 20, 2026Latest source record: Aug 5, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Aug 5, 2015
Approved
Time to decision
218 days
Received Dec 30, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
Device type
- Device class
- Class III
- Regulation
- 21 CFR 878.3540
FDA's approval statement
As written in FDA's record.
APPROVAL FOR TWENTY-EIGHT (28) ADDITIONAL NATRELLE 410 DEVICES THAT INCLUDE: FOUR (4) SIZES OF STYLE FL 410; FOUR (4) SIZES OF STYLE ML 410; ONE (1) SIZE OF STYLE LM 410; THREE (3) SIZES OF STYLE LL 410; TWO (2) SIZES OF STYLE LF 410; FOUR (4) SIZES OF STYLE FX 410; FOUR (4) SIZES OF STYLE MX 410; AND SIX (6) SIZES OF STYLE LX 410. THESE TWENTY-EIGHT (28) ADDITIONAL NATRELLE 410 DEVICES ENCOMPASS A RANGE OF: VOLUME = 140-775 CC; WIDTH = 9.5-15.5 CM; HEIGHT = 7.6-16.0 CM; AND PROJECTION = 2.9-7.1 CM.
Source documents
Other decisions for Allergan
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SKINVIVE by JUVEDERM®PMA supplement
P110033-S099 · Decided Jun 11, 2026 · 394 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.